Bifunctional Avidin with Covalently Modifiable Ligand Binding Site
Author Information
Author(s): Jenni Leppiniemi, Juha A. E. Määttä, Henrik Hammaren, Mikko Soikkeli, Mikko Laitaoja, Janne Jänis, Markku S. Kulomaa, Vesa P. Hytönen
Primary Institution: Institute of Medical Technology, University of Tampere and Tampere University Hospital, Tampere, Finland
Hypothesis
Can a single point mutation in avidin create a covalently modifiable ligand binding site?
Conclusion
The engineered bifunctional avidin allows for the selective covalent linking of thiol-reactive molecules while maintaining some biotin-binding capability.
Supporting Evidence
- The S16C mutation introduced a thiol group that can be covalently modified.
- Binding assays showed that the modified avidin retained some affinity for biotin.
- Fluorescent labels were successfully coupled to the modified avidin.
Takeaway
Scientists changed a part of a protein called avidin so it can stick to other things better, while still holding onto biotin a little bit.
Methodology
The study involved site-directed mutagenesis to introduce a cysteine residue into avidin, followed by biochemical assays to test binding properties.
Limitations
The study primarily focused on a specific mutation and its effects, which may not generalize to all avidin applications.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website